Levothyroxine Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0615-8574
  • Package NDC 0615-8574-05
  • Package NDC 0615-8574-14
  • Package NDC 0615-8574-39
  • Application number NDA021210
  • SPL ID 4caa5e76-0e12-4c19-9cc7-af7365f7dc90
  • SPL set ID abe173cc-1579-43a5-b12d-a31958d0a539
  • UNII 9J765S329G
  • RxCUI 892246
  • RxCUI 966220
  • RxCUI 966221
  • RxCUI 966222
  • RxCUI 966224
  • RxCUI 966225
  • RxCUI 966248
  • RxCUI 966249
  • RxCUI 966253
  • RxCUI 966270

What the source publishes

Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Active ingredients
Levothyroxine Sodium
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0615-8574_4caa5e76-0e12-4c19-9cc7-af7365f7dc90
{
  "name": "Levothyroxine Sodium",
  "splId": "4caa5e76-0e12-4c19-9cc7-af7365f7dc90",
  "labels": [
    {
      "setId": "abe173cc-1579-43a5-b12d-a31958d0a539",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abe173cc-1579-43a5-b12d-a31958d0a539",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=abe173cc-1579-43a5-b12d-a31958d0a539"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "NCS HealthCare of KY, LLC dba Vangard Labs",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "15 TABLET in 1 BLISTER PACK (0615-8574-05)",
      "package_ndc": "0615-8574-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251209"
    },
    {
      "sample": false,
      "description": "14 TABLET in 1 BLISTER PACK (0615-8574-14)",
      "package_ndc": "0615-8574-14",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251209"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BLISTER PACK (0615-8574-39)",
      "package_ndc": "0615-8574-39",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251209"
    }
  ],
  "productId": "0615-8574_4caa5e76-0e12-4c19-9cc7-af7365f7dc90",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "0615-8574",
  "deaSchedule": null,
  "genericName": "Levothyroxine Sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LEVOTHYROXINE SODIUM",
      "strength": ".05 mg/1"
    }
  ],
  "applicationNumber": "NDA021210",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20031201",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "9J765S329G"
    ],
    "rxcui": [
      "892246",
      "966220",
      "966221",
      "966222",
      "966224",
      "966225",
      "966248",
      "966249",
      "966253",
      "966270"
    ],
    "spl_set_id": [
      "abe173cc-1579-43a5-b12d-a31958d0a539"
    ],
    "manufacturer_name": [
      "NCS HealthCare of KY, LLC dba Vangard Labs"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0615-8574_4caa5e76-0e12-4c19-9cc7-af7365f7dc90"